Legend Biotech Corporatio...

NASDAQ: LEGN · Real-Time Price · USD
37.47
-0.24 (-0.64%)
At close: Aug 15, 2025, 3:59 PM
37.50
0.09%
After-hours: Aug 15, 2025, 06:06 PM EDT

Legend Biotech Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
286.75M 1.28B 786.03M 688.94M
Short-Term Investments
835.93M 31M 239.62M 193.46M
Long-Term Investments
4.36M 4.36M 395K 4.71M
Other Long-Term Assets
6.06M 152.42M 66.76M 5.15M
Receivables
124.89M 157.06M 45.52M 50.5M
Inventory
23.9M 19.43M 10.35M 1.75M
Other Current Assets
70K 357K 45.51M 9.49M
Total Current Assets
1.28B 1.5B 1.1B 948.75M
Property-Plant & Equipment
201.59M 189.68M 161.67M 155.08M
Goodwill & Intangibles
174.22M 4.06M 3.41M 4.68M
Total Long-Term Assets
386.24M 350.81M 231.84M 169.62M
Total Assets
1.67B 1.85B 1.33B 1.12B
Account Payables
37.19M 20.16M 32.89M 7.04M
Deferred Revenue
46.87M 53.01M 451K 60.95M
Short-Term Debt
4.79M n/a 3.56M n/a
Other Current Liabilities
118.73M 68K 191.28M 192.56M
Total Current Liabilities
277.64M 216.42M 297.79M 280.27M
Long-Term Debt
301.2M 281.33M 260.93M 120.46M
Other Long-Term Liabilities
n/a 56K 7.89M 2.26M
Total Long-Term Liabilities
351.96M 380.82M 288.86M 366.89M
Total Liabilities
629.61M 597.24M 586.65M 647.16M
Total Debt
350.6M 328.67M 284.53M 122.97M
Common Stock
37K 36K 33K 31K
Retained Earnings
-1.66B -1.48B -966.46M -816.97M
Comprehensive Income
-68.16M 98.92M 744.28M 471.18M
Shareholders Equity
1.04B 1.25B 744.31M 471.21M
Total Investments
840.3M 35.37M 239.62M 198.16M